Association of markers for TGFβ3, TGFβ2 and TIMP1 with systemic sclerosis

Revmatologiia

Volumn 39, Issue 12, 2000, Pages 1332-1336

  Susol, E ^a   Rands, A L ^b   Herrick, A ^a   McHugh, N ^b   Barrett, J H ^a   Ollier, W E R ^a   Worthington, J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

Fibrosis; Microsatellite markers; Systemic sclerosis; TDF ; TIMP

Indexed keywords

BIOLOGICAL MARKER; MICROSATELLITE DNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; COLLAGEN TYPE 5; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; ARTICLE; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTEMIC SCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; GENE FREQUENCY; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOTYPE; MAJOR CLINICAL STUDY; MARKER GENE; PRIORITY JOURNAL; SKIN FIBROSIS; X CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034507939     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5.
2. McGregor AR, Watson A, Yunis E et al. Familial clustering of scleroderma spectrum disease. Am J Med 1988;84:1023-32.
3. Silman AJ, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90.
4. Siracusa LD, McGrath R, Ma Q et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1996;6:300-13.
5. Christner PJ, Siracusa LD, Hawkins DF et al. A high resolution linkage map of the tight skin 2 (Tsk2) locus: a mouse model for scleroderma (SSc) and other cutaneous fibrotic diseases. Arthritis Rheum 1996;39(Suppl. 9):1234.
6. Fanning GC, Rydberg B, Black CM, Welsh KI. A first round screen of multiple candidate polymorphism identifies genes and gene interactions involved in the development of SSc and different organ involvements. Clin Exp Rheumatol 1998;16:148a.
7. Compasso S, Colombo G, Colombo G et al. Polymorphism of the serotonin-transporter promoter region in 75 SSc patients. Clin Exp Rheumatol 1998;16:45.
8. Artlett CM, Jimenez SA. IL-1 receptor antagonist A2 VNTR allele is associated with systemic sclerosis. Arthritis Rheum 1996;39(Suppl. 9):1231.
9. Reveille JD. Molecular genetics of systemic sclerosis. Curr Opin Rheumatol 1993;5:753-9.
10. Takehara K. Induction of subcutaneous tissue fibrosis in newborn mice by TGF-beta. Simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Clin Exp Rheumatol 1998;16:68.
11. Gay S, Boulware DW, Gay RE. Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosis. Clin Dermatol 1994;12:419-24.
12. Kikuchi K, Kadono T, Furue M, Tamaki K. Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 1997;108:281-4.
13. Andrikopoulos K, Liu X, Keene DR, Jaenisch R, Ramirez F. Targeted mutation in the COL5A2 gene reveals a regulatory role for type V collagen during matrix assembly. Nature Genet 1995;9:31-6.
14. Mehta CR. The exact analysis of contingency tables in medical research. Stat Methods Med Res 1994;3:135-56.
15. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor β1 gene: association with transforming growth factor-beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-20.
16. O'Kane S, Ferguson MWJ. TGFβ's and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
17. Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-beta1 and TGF-beta2 or exogenous addition of TGFβ3 to cutaneous rat wounds reduces scarring. J Cell Biol 1995;108:985-1002.
18. Helman S, Cotton AS, Jayson MIV, Hoyland J, Herrick A, Freemint AJ. Microvascular abnormality and TGFβ in systemic sclerosis skin. Br J Rheumatol 1997;36(Suppl. 1):30.
19. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995;270:3423-38.
20. Xiong M, Jin L. Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods. Am J Hum Genet 1999;64:629-40.